Valuation vs Own History COMMODITY
— slow-moving; 60d lag; EV/EBITDA canonical
Research notes (read before interpreting):- The news-vs-expectations thesis is UNTESTED by the backtest (look-ahead-impossible). Only Agent 6 live forward-tracking can validate whether news_adj improves outcomes. Treat news as a bounded refinement on trial, not a proven driver.
- Fundamentals are annual with a 60-day reporting lag; EV/EBITDA is the valuation metric (P/E broke on 45 loss-year rows). Valuation reads are slow-moving, not point-in-time precise.
Percentile within this ticker's own 6-year fundamental history. High = expensive vs itself.
| FY | EV/EBITDA | P/E | P/S | Revenue | EPS |
| 2025 |
7.67x |
15.95x |
3.64x |
$37.4B |
$7.65 |
| 2024 |
12.59x |
136.53x |
4.21x |
$25.1B |
$0.70 |
| 2023 |
37.00x |
neg |
4.92x |
$15.5B |
$-5.34 |
| 2022 |
3.76x |
7.34x |
2.07x |
$30.8B |
$7.81 |
| 2021 |
6.37x |
14.15x |
2.99x |
$27.7B |
$5.23 |
Earnings Surprise Track Record COMMODITY
Canonical signal: avoid-misses is the durable edge (misses lag the basket ~4%/21d excess); beats merely match the sector once drift is stripped. Regime-dependent, effectively small-sample — not proven.
| Date | EPS act | EPS est | EPS surp% |
Rev surp% | Excess/21d |
| 2026-03-18 |
$12.20 |
$9.19 |
+32.8% |
+19.5% |
-18.0% |
| 2025-12-17 |
$4.78 |
$3.96 |
+20.7% |
+5.7% |
+43.9% |
| 2025-09-23 |
$3.03 |
$2.86 |
+5.9% |
+0.9% |
+22.0% |
| 2025-06-25 |
$1.91 |
$1.60 |
+19.4% |
+4.9% |
-18.8% |
| 2025-03-20 |
$1.56 |
$1.43 |
+9.1% |
+2.0% |
-11.8% |
| 2024-12-18 |
$1.79 |
$1.75 |
+2.3% |
-0.1% |
+4.0% |
| 2024-09-25 |
$1.18 |
$1.12 |
+5.4% |
+1.3% |
-4.7% |
| 2024-06-26 |
$0.62 |
$0.48 |
+29.1% |
+2.1% |
-9.3% |
| 2024-03-20 |
$0.42 |
$-0.25 |
+266.2% |
+8.9% |
+6.9% |
| 2023-12-20 |
$-0.95 |
$-0.99 |
+4.0% |
-1.7% |
-4.9% |
| 2023-09-27 |
$-1.07 |
$-1.18 |
+9.3% |
+2.5% |
+6.0% |
| 2023-06-28 |
$-1.43 |
$-1.58 |
+9.5% |
+2.9% |
+4.8% |
| 2023-03-28 |
$-1.91 |
$-0.66 |
-189.4% |
-0.7% |
+1.9% |
| 2022-12-21 |
$-0.04 |
$-0.01 |
-194.6% |
-1.2% |
+11.4% |
| 2022-09-29 |
$1.45 |
$1.30 |
+11.5% |
-1.3% |
+1.1% |
| 2022-06-30 |
$2.59 |
$2.43 |
+6.6% |
-0.0% |
-0.3% |
| 2022-03-29 |
$2.14 |
$1.97 |
+8.6% |
+3.4% |
-1.8% |
| 2021-12-20 |
$2.16 |
$2.11 |
+2.4% |
+2.2% |
-1.1% |
| 2021-09-28 |
$2.42 |
$2.33 |
+3.9% |
— |
-9.7% |
| 2021-06-30 |
$1.88 |
$1.72 |
+9.3% |
— |
-5.3% |
Post-Earnings Revisions COMMODITY
— how consensus moved after each print
No computed revisions yet — snapshots need to bracket a print.
Consensus EPS Revision Trajectory COMMODITY
Forward-year consensus EPS over time — shows how estimates move after each print. Data accrues forward from snapshot start date.
News Lean UNPROVEN LIVE
— UNPROVEN LIVE-ONLY: no historical validation possible
▼ bearish
near
2026-07-28
CXMT 465% IPO pop and Apple-testing report spooked market despite CXMT having zero HBM exposure — analysts (UBS $1,625, KeyBanc $1,750) say long-term thesis intact, but retail selling commodity-DRAM narrative missed that CXMT is a generation behind in AI memory.
source ↗
▲ bullish
near
2026-07-24
Q4 guidance crushed consensus by 15%—one of the largest guidance beats in memory history; 16 LTAs lock in demand across hyperscalers and automakers; stock up 700% YoY but fundamental beat was large enough to reset the bar higher
source ↗
▼ bearish
near
2026-07-21
Classic retail trap: headline numbers were record-setting but stock sold off hard on CXMT IPO fears, potential HBM export controls, and TSMC capex overhang — beat vs reported consensus but failed buy-side whisper
source ↗
● neutral
near
2026-07-17
Strong $33.5B Q3 guidance and Citi upside catalyst watch are bullish; but SKHY Nasdaq listing lets funds that were MU-only-by-default now rotate into KRX-equivalent - technical supply overhang on a stock with great fundamentals
source ↗
▲ bullish
near
2026-07-16
KeyBanc PT raise signals conviction that pullback (~22% from highs) is overdone given $41.46B Q3 beat vs $35.84B expected; Anthropic partnership and 16 long-term agreements lock in ~50% of revenue—analyst sees dip as opportunity, not distribution
source ↗
Analyst Context — the consensus we're trying to beat
Consensus PT
$1,575.91
+92.1% from current
Price targets from FMP consensus. Not a recommendation.